DIAGNOSTIC METHOD AND DEVICE FOR ASSESSING HUMAN JOINT FLUID REACTIVITY TO CoCrMo ALLOY

Patent metadata

Field	Value
Publication number	US-2016299093-A1
Application number	US-201415100651-A
Country	US
Kind code	A1
Filing date	Dec 2, 2014
Priority date	Dec 2, 2013
Publication date	Oct 13, 2016
Grant date	—

Abstract

A chamber for testing the reactivity of patient fluids to a metallic implant alloy, such as CoCrMo, and a method of determining the reactivity of the patent to the alloy. A sealed mini-electrochemical cell incorporates the alloy surface as well as reference and counter electrodes coupled to a potentiostat for performing electrochemical measurements of the alloy surface while it is in direct contact with freshly harvested human fluids. Freshly obtained body fluids are thus assessed in terms of their bioelectrochemical reactivity with the alloy surface as a measure of the likely reactivity of the patient to the alloy if it were to be implanted into the patient.

First claim

What is claimed:

1 . A testing apparatus for determining whether a patient may have sensitivity to a metallic medical implant, comprising:
a electrochemical cell defining a chamber therein and having a port through which a sample of fluid may be introduced into the chamber; a metallic biomaterial alloy surface positioned in the chamber; a reference electrode positioned in the chamber; a counter electrode positioned in the chamber; and a potentiostat coupled to the metallic biomaterial alloy surface, the reference electrode, and the counter electrode.

2 . The apparatus of claim 1 , wherein the metallic biomaterial alloy surface is a cobalt-chromium molybdenum (CoCrMo) alloy.

3 . The apparatus of claim 1 , wherein the metallic biomaterial alloy surface is a titanium alloy.

4 . The apparatus of claim 3 , wherein the titanium alloy is selected from the group consisting of NiTi shape memory alloy, CP-Ti, Ti-6Al-4V and Ti-6Al-7Nb.

5 . The apparatus of claim 1 , wherein the potentiostat is configured to measure the open circuit potential of the CoCrMo alloy surface.

6 . The apparatus of claim 1 , wherein the potentiostat is configured to measure the impedance characteristics of the CoCrMo alloy surface.

7 . The apparatus of claim 1 , wherein the potentiostat is configured to measure the polarization of the CoCrMo alloy surface.

8 . A method of determining whether a patient may have sensitivity to a medical implant, comprising the steps of:
collecting a sample of fluid from a patient; providing an electrochemical cell defining a chamber therein and having a port through which the sample of fluid may be introduced into the chamber, a CoCrMo alloy surface positioned in the chamber, a reference electrode positioned in the chamber, a counter electrode positioned in the chamber, and a potentiostat coupled to the CoCrMo alloy surface, the reference electrode, and the counter electrode; inserting the sample of fluid through the port of the electrochemical cell into contact with the CoCrMo alloy surface; measuring the electrochemical response of the CoCrMo alloy surface to the fluid over time; and determining whether the patient may have an adverse reaction to a CoCrMo alloy implant based upon the electrochemical response of the CoCrMo alloy surface to the fluid of the patient.

9 . The method of claim 8 , wherein the step of measuring the electrochemical response of the CoCrMo alloy surface to the fluid over time comprises measuring the open circuit potential of the CoCrMo alloy surface.

10 . The method of claim 9 , wherein the step of determining whether the patient may have an adverse reaction to a CoCrMo alloy implant is based on whether the open circuit potential becomes more positive when the sample of fluid is placed into contact with the CoCrMo alloy surface.

11 . The method of claim 8 , wherein the step of measuring the electrochemical response of the CoCrMo alloy surface to the fluid over time comprises measuring the impedance of the CoCrMo alloy surface.

12 . The method of claim 8 , wherein the step of determining whether the patient may have an adverse reaction to a CoCrMo alloy implant is based on whether the impedance decreases logarithmically when the sample of fluid is placed into contact with the CoCrMo alloy surface.

13 . The method of claim 8 , wherein the step of measuring the electrochemical response of the CoCrMo alloy surface to the fluid over time comprises measuring the polarization of the CoCrMo alloy surface.

14 . The method of claim 8 , wherein the step of determining whether the patient may have an adverse reaction to a CoCrMo alloy implant is based on whether the polarization increases when the sample of fluid is placed into contact with the CoCrMo alloy surface.

Assignees

• Gilbert Jeremy
• Univ Syracuse

Inventors

• Gilbert Jeremy

Classifications

• G01N27/22

  by investigating capacitance · CPC title

• A61B5/4851

  Prosthesis assessment or monitoring · CPC title

• A61B5/14546

  for measuring analytes not otherwise provided for, e.g. ions, cytochromes · CPC title

• A61B5/1468

  using chemical or electrochemical methods, e.g. by polarographic means · CPC title

• G01N27/041

  of a solid body · CPC title